RxDoctor Payments Data

Paul Goodman

Podiatrist · Glenview, ILNPI 1295781433

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,119 of the $12,754 with a category attached, or 63.7%. 36 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 32.5% of the total. Reporting peaked in 2024 at $5,498 and has fallen 79.4% since, to $1,132 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,754in general payments, 2019–2025

Across 190 payments — averaging $67.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fusion Orthopedics USA, LLC$4K
  • Smith+Nephew$1K
  • Stryker$1K
  • Zimmer Biomet$1K
  • Treace Medical Concepts, Inc.$1K
  • Medartis Inc.$465
  • plus $4K from 30 others

What the payments were for

  • Consulting fees$3,60028%
  • Travel & lodging$1,0358%
  • Food & beverage$8,11964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,754 in reported general payments places this provider in the 90th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$271,852
Medicare patients
623
Services billed
2,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib64$788
Methylprednisolone66$425
Colchicine17$319
Minocycline Hcl12$281
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$277
Clindamycin Hcl15$219
Hydromorphone Hcl58$209
Cefadroxil22$208
Doxycycline Hyclate22$148
Ciprofloxacin Hcl14$146
Meloxicam24$99

Paid to pharmacies, not to this prescriber.

Other podiatrist in Glenview

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →